Grand River Aseptic Manufacturing Secures Two Contracts
Grand River Aseptic Manufacturing has announced that the company executed two commercial production contracts in one day.
Grand River Aseptic Manufacturing (GRAM), a parenteral contract manufacturing organization, has announced that the company executed two commercial production contracts in one day.
The first contract was signed with a medium sized, publicly-held pharmaceutical company; and the second contract was signed with a multi-billion dollar biopharmaceuticals company.
GRAM specializes in pre-clinical, clinical, and commercial manufacturing and offers sterile product development and manufacture, lyophilization, terminal sterilization and analytical and microbiological testing, stability sample storage, labeling, and packaging storage and distribution.
Source: Grand River Aseptic Manufacturing
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
